Lupin Patents – Key Insights and Stats

Lupin has a total of 3066 patents globally, out of which 1006 have been granted. Of these 3066 patents, more than 38% patents are active. India is where Lupin has filed the maximum number of patents, followed by the USA and Europe (EPO). Parallelly, The India seems to be the main focused R&D centre and is also the origin country of Lupin.

Lupin is an Indian multinational pharmaceutical company based in Mumbai founded in 1968 by Desh Bandhu Gupta. The primary areas of interest for the company include paediatrics, cardiology, anti-infectives, diabetology, asthma, and anti-tuberculosis.

Do read about some of the most popular patents of Lupin which have been covered by us in this article and also you can find Lupin patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lupin patent portfolio.

How many patents does Lupin have?

Lupin has a total of 3066 patents globally. These patents belong to 987 unique patent families. Out of 3066 patents, 1189 patents are active.

How Many Patents did Lupin File Every Year?

Lupin Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLupin Applications FiledLupin Patents Granted
20227271
20218961
202023896
20197573
201814086
201714794
2016194103
201522980
201424647
201328331
201221920
201118022

How many Lupin patents are Alive/Dead?

Worldwide Patents

Lupin Patent Portfolio

How Many Patents did Lupin File in Different Countries?

Lupin Worldwide Patent Filing

Countries in which Lupin Filed Patents

CountryPatents
India585
United States Of America354
Europe199
Australia149
Japan117
South Africa100
Mexico99
Canada96
Brazil92
Germany66
China54
Korea (South)49
Philippines39
Spain35
Singapore34
Hong Kong (S.A.R.)32
Austria31
Indonesia31
Malaysia30
Israel29
New Zealand28
Colombia27
Chile22
Russia21
Viet Nam19
Peru18
Africa18
Eurasia17
Costa Rica16
Ukraine14

Where are Research Centers of Lupin Patents Located?

R&D Centres of Lupin

10 Best Lupin Patents

US20050153946A1 is the most popular patent in the Lupin portfolio. It has received 117 citations so far from companies like Sun Pharmaceutical Industries.

Below is the list of 10 most cited patents of Lupin:

Publication NumberCitation Count
US20050153946A1117
WO2009008005A167
WO2013136249A162
WO2012069917A158
JP2015504087A51
WO2013164769A148
WO2015075640A147
WO2008010238A244
WO2009047801A142
WO2009109999A140

What are Lupin key innovation segments?

What Technologies are Covered by Lupin?

The chart below distributes patents filed by Lupin in different countries on the basis of the technology protected in patents. It also represents the markets where Lupin thinks it’s important to protect particular technology inventions.

R&D Focus: How has Lupin search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Lupin?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.